Plasma and Cancer Treatment
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 31 December 2025 | Viewed by 31
Special Issue Editors
Interests: cold plasma; cancer treatments; plasma medicine; plasma physics
Special Issues, Collections and Topics in MDPI journals
Interests: plasma medicine; cancer biology; biochemistry
Special Issue Information
Dear Colleagues,
This Special Issue aims to explore the innovative applications of Cold Atmospheric Plasma (CAP) in cancer treatment, focusing on both its potential and the challenges of integrating plasma technology into clinical oncology. CAP, a partially ionized gas at room temperature, has gained attention as a non-invasive approach to target and treat various cancer types, offering novel therapeutic strategies. Plasma interacts with cells, tissues, and tumors through reactive oxygen and nitrogen species, which can induce cell death, enhance chemotherapy efficacy, and even facilitate immune responses.
Key areas of interest include the molecular and genetic mechanisms underlying plasma-induced cancer cell apoptosis, the combination of CAP with traditional therapies (such as chemotherapy and radiation), and the potential of plasma to induce oxidative stress in cancer treatment. The issue will cover various applications of CAP in cancer research, ranging from in vitro studies where CAP is used to treat cultured cancer cells to in vivo research involving animal models for evaluating the therapeutic potential of CAP in solid tumors. Additionally, the issue will discuss ongoing preclinical or clinical trials and the translational challenges involved in bringing CAP-based therapies from the laboratory to patient care. Additionally, the safety, regulatory hurdles, and clinical translation of CAP-based therapies will be addressed, providing a comprehensive overview of their potential in cancer care.
The issue will feature original research articles and reviews that highlight advancements in plasma technology, its therapeutic efficacy, and the promise it holds for revolutionizing cancer treatment.
Prof. Dr. Michael Keidar
Dr. Vikas Soni
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cold atmospheric plasma (CAP)
- cancer treatment
- plasma medicine
- reactive oxygen species (ROS)
- apoptosis
- tumor
- non-thermal plasma
- plasma oncology
- cancer and molecular biology
- clinical translation
- in vivo/preclinical
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
